ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,061.74
-1.06%
Dow Jones
37,932.48
-1.18%
US Dollar vs MXN
17.1178
0.61%
Brent Oil
86.075
-1.39%
Bitcoin
60,107.59
-5.80%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Avenue Therapeutics Inc (ATXI)

  7. Avenue Therapeutics Inc (ATXI) Noticias

ATXI Avenue Therapeutics Inc

5.02
0.5053 (11.19%)
Última actualización: 14:15:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Avenue Therapeutics Inc ATXI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.5053 11.19% 5.02 14:15:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.38 4.38 5.21 4.5147
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202407:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
24/4/202406:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
25/3/202407:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
18/3/202415:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/3/202407:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/3/202407:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
08/3/202415:31EDGAR2Form PRE 14C - Other preliminary information statements
08/3/202415:15EDGAR2Form 8-K - Current report
22/2/202407:30GLOBEAvenue Therapeutics Announces Publication in Drug..
01/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
29/1/202407:00EDGAR2Form DEF 14C - Other definitive information statements
24/1/202415:11EDGAR2Form S-3 - Registration statement under Securities Act of..
17/1/202416:05EDGAR2Form PRE 14C - Other preliminary information statements
12/1/202405:01EDGAR2Form 8-K - Current report
11/1/202407:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
08/1/202416:28EDGAR2Form 8-K - Current report
05/1/202408:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
04/1/202407:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
02/1/202407:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
13/12/202315:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/12/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202307:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
28/11/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/11/202315:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202312:19EDGAR2Form 8-K - Current report
13/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
02/11/202315:10EDGAR2Form 8-K - Current report
02/11/202314:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202308:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/10/202308:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
05/10/202316:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/9/202316:23EDGAR2Form S-1/A - General form for registration of securities..
28/9/202315:25EDGAR2Form 8-K - Current report
27/9/202315:03EDGAR2Form 8-K - Current report
18/9/202316:18EDGAR2Form S-1 - General form for registration of securities under..
08/9/202315:15EDGAR2Form 8-K - Current report
05/9/202307:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
14/8/202315:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
11/8/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:20EDGAR2Form 8-K - Current report
10/8/202315:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/8/202307:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/7/202307:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/7/202307:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
21/7/202315:37EDGAR2Form 8-K - Current report
05/7/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ATXI
Avenue Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados